Menu Search
Equities

Palisade Bio Inc

7NS0:DEU

Palisade Bio Inc

Actions
  • Price (EUR)4.91
  • Today's Change0.00 / 0.00%
  • Shares traded1.11k
  • 1 Year change-40.65%
  • Beta--
Data delayed at least 15 minutes, as of Apr 05 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Palisade Bio Inc grew revenues -- from 0.00 to 250.00k while net income improved from a loss of 14.26m to a smaller loss of 12.30m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-90.97%
Return on equity-110.11%
Return on investment-109.07%
More ▼

Cash flow in USDView more

In 2023, Palisade Bio Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 11.19m or 4,474.40% of revenues. In addition the company used 11.13m for operations while cash used for investing totalled 4.00k.
Cash flow per share-18.26
Price/Cash flow per share--
Book value per share10.30
Tangible book value per share10.30
More ▼

Balance sheet in USDView more

Palisade Bio Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio4.34
Quick ratio--
Total debt/total equity0.0351
Total debt/total capital0.0339
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.